| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/03/2006 | WO2005123140A3 Preparation of macromolecular conjugates by four-component condensation reaction |
| 08/03/2006 | WO2005117984A3 Albumin-binding conjugates comprising a fatty acid and peg |
| 08/03/2006 | WO2005116655A3 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | WO2005113011A3 Prodrugs of ion channel modulating compounds and uses thereof |
| 08/03/2006 | WO2005113007A3 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 08/03/2006 | WO2005112889A3 Transmucosal delivery formulations |
| 08/03/2006 | WO2005107719A3 Pharmaceutical composition comprising hydrophobic drug having improved solubility |
| 08/03/2006 | WO2005097195A3 Methods of reducing aggregation of il-1ra |
| 08/03/2006 | WO2005091753A3 Flexible vaccine assembly and vaccine delivery platform |
| 08/03/2006 | WO2005089808A3 Antibody calicheamicin conjugates |
| 08/03/2006 | WO2005087195A3 Novel compositions for topical delivery |
| 08/03/2006 | WO2005072710A3 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 08/03/2006 | WO2004086412A3 Radiation protection by gamma-tocotrienol |
| 08/03/2006 | US20060173076 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172969 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability |
| 08/03/2006 | US20060172966 Immunostimulatory G, U-containing oligoribonucleotides |
| 08/03/2006 | US20060172955 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172933 Natriuretic compounds, conjugates, and uses thereof |
| 08/03/2006 | US20060172418 Hypercoiling polymers and their use in cellular delivery |
| 08/03/2006 | US20060172059 Method of inhibiting water content variation of composition and use thereof |
| 08/03/2006 | US20060172009 The formulation and presentation of medicaments |
| 08/03/2006 | US20060172001 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 08/03/2006 | US20060171993 Method of improving antioxidant status of an infant |
| 08/03/2006 | US20060171992 Blood glucose regulating composition |
| 08/03/2006 | US20060171987 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix |
| 08/03/2006 | US20060171984 Device having hydration inhibitor |
| 08/03/2006 | US20060171969 Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 08/03/2006 | US20060171934 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2006 | US20060171916 water insoluble polyallylamine copolymer (hydrochloride) crosslinked with epichlorohydrin crosslinking agent; decreasing serum level of phosphate by binding phosphate in gastrointestinal tract, without increasing absorption of any clinically undesirable material, as calcium or aluminum; hyperphosphatemia |
| 08/03/2006 | US20060171898 Corticosteroid-containing pharmaceutical composition |
| 08/03/2006 | US20060171893 Antineoplastic agents targeted via glut transporters |
| 08/03/2006 | DE60115402T2 Neues selbstemulgierendes arzneistoffverabreichungssystem New self-emulsifying drug delivery system |
| 08/03/2006 | CA2596548A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | CA2596230A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | CA2596131A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | CA2596058A1 Method of producing coated fine particles |
| 08/03/2006 | CA2596053A1 Esterified catechins, processes for producing the same, and foods and beverages as well as cosmetics containing such esterified catechins |
| 08/03/2006 | CA2596035A1 Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents |
| 08/03/2006 | CA2595894A1 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 08/03/2006 | CA2595778A1 Anti-muc1 .alpha..beta. antibodies |
| 08/03/2006 | CA2595651A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 08/03/2006 | CA2595457A1 Control of drug release by transient modification of local microenvironments |
| 08/03/2006 | CA2595348A1 Stabilised plant extract and its therapeutic use |
| 08/03/2006 | CA2593825A1 Solid dispersion comprising tacrolimus and enteric-coated macromolecule |
| 08/03/2006 | CA2590338A1 Compositions and methods for treating cardiac conditions |
| 08/03/2006 | CA2567789A1 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685837A1 Percutaneous absorption type cerebral protective agent |
| 08/02/2006 | EP1685830A1 Plaster |
| 08/02/2006 | EP1685253A2 Adapter for coupling a substance which is to be coupled to a cell surface |
| 08/02/2006 | EP1685223A1 Use of a solution comprising at least one nonionic surfactant |
| 08/02/2006 | EP1685184A1 Tri-block copolymers and a process for the preparation of the same |
| 08/02/2006 | EP1685153A1 Targeting compositions and preparation thereof |
| 08/02/2006 | EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 08/02/2006 | EP1684808A1 A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes |
| 08/02/2006 | EP1684801A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 08/02/2006 | EP1684799A2 Rescue agents for treating botulinum toxin intoxications |
| 08/02/2006 | EP1684792A2 Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
| 08/02/2006 | EP1684767A1 Soft steroid compositions for use in dry powder inhalers |
| 08/02/2006 | EP1684760A1 Method and composition for treatment of cutaneous lesions |
| 08/02/2006 | EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 08/02/2006 | EP1684730A1 Pharmaceutical composition having a cationic excipient |
| 08/02/2006 | EP1684727A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 08/02/2006 | EP1684724A2 Enhanced drug delivery |
| 08/02/2006 | EP1684723A1 Contrast medium comprising liposomes containing hydrophobic chelate compound |
| 08/02/2006 | EP1684721A2 Aerosol formulations comprising a carboxylic acid surfactant |
| 08/02/2006 | EP1684719A2 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 08/02/2006 | EP1684718A1 Methods of preparing a foam comprising a sclerosing agent |
| 08/02/2006 | EP1684716A1 Dispersions and methods of preparing them |
| 08/02/2006 | EP1684700A2 Use of perfluoropolyether phosphates as stabilizing agents for polyphenols in cosmetic and/or dermatological compositions |
| 08/02/2006 | EP1684681A1 Transdermal high and low molecular weight compounds |
| 08/02/2006 | EP1492821B1 Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 08/02/2006 | EP1481017B1 Biodegradable polymeric material for biomedical applications |
| 08/02/2006 | EP1455828B1 Photosensitizer functionalised nanoparticles |
| 08/02/2006 | EP1435971B1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
| 08/02/2006 | EP1341565B1 Drug delivery compositions and coated medical devices |
| 08/02/2006 | EP1328280B1 Composition for the treatment of dysglucaemia and method for the production of said composition |
| 08/02/2006 | EP1296656B1 Method for preparing a composition |
| 08/02/2006 | EP1276485B1 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1265598B1 Pharmaceutical composition for application to mucosal surfaces |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |
| 08/02/2006 | EP0979243B1 Activation of peptides |
| 08/02/2006 | EP0923380A4 Povidone iodine (pvp-i) alcohol gel antimicrobial pre-operative skin preparation |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0866713B1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 08/02/2006 | EP0758249B1 Programmable genotoxic agents and uses therefor |
| 08/02/2006 | EP0730472B1 Immobilized labelling method |
| 08/02/2006 | CN1812814A Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 08/02/2006 | CN1812813A Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 08/02/2006 | CN1812799A Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 08/02/2006 | CN1812793A Sustained drug-relase particles and process for producing the same |
| 08/02/2006 | CN1812785A New effector conjugates, process for their production and their pharmaceutical use |
| 08/02/2006 | CN1812774A Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same |
| 08/02/2006 | CN1812773A Polyethylene oxide-based films and drug delivery systems made therefrom |
| 08/02/2006 | CN1812770A Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix |